GTGuoguo Tang

Guoguo Tang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guoguo Tang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Chao Hou

    Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032

    2 shared publications
  • Taoyu Chen

    Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China

    2 shared publications
  • Tianhao Li

    Department of Biomedical Informatics, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China

    2 shared publications
  • Tingting Li

    Peking University Cancer Hospital 1 Breast Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), and Institute, Beijing, China

    2 shared publications
  • Jing Hong

    Department of Ophthalmology, Peking University Third Hospital, Beijing, China

    1 shared publication
  • Kaiqiang You

    Peking University Cancer Hospital 1 Breast Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), and Institute, Beijing, China

    1 shared publication

Latest Publications

  • Open Access

    Corneal Epithelial Tissue Engineering Strategy Based on Cell Viability Optimization: A Review and Prospects

    by Guoguo Tang, Miaomiao Chi, Yang Zhai, Rongmei Peng, Jing Hong

    Corneal transplantation is often considered the last resort for severe corneal epithelial disorders, especially limbal stem cell deficiency (LSCD). Tissue engineering offers novel strategies to mitigate the shortage of corneal transplant donors. However, low cell viability and compromised functionality in tissue engineering represent a major challenge. In this review, we describe the key characteristics required for corneal epithelium bioscaffolds. We summarize the research progress centered on optimizing cell activity and functionality in the past 10 years from four key perspectives: the sourcing of cells, seed cell pretreatments, biomaterial optimization, and engineered culture system innovation. The sources, isolation, and induction methods of seed cells are described, and the advantages and disadvantages of existing clinical treatment methods are compared. Furthermore, we compare existing clinical therapies and summarize promising seed cell pretreatment strategies for the first time. Several innovative engineered cell culture systems are exhibited as well. We demonstrated how to preserve cell viability through bioscaffold stiffness modulation, topographic design, and application of innovative fabrication techniques. Finally, we propose a personalized and precise regeneration strategy based on high-resolution images, digital modeling, bioprinting, and machine learning.


  • Open Access

    PhaSeDis: A Manually Curated Database of Phase Separation–disease Associations and Corresponding Small Molecules

    by Taoyu Chen, Guoguo Tang, Tianhao Li, Zhining Yanghong, Chao Hou, Zezhou Du, Kaiqiang You, Liwei Ma, Tingting Li

    Biomacromolecules form membraneless organelles through liquid–liquid phase separation in order to regulate the efficiency of particular biochemical reactions. Dysregulation of phase separation might result in pathological condensation or sequestration of biomolecules, leading to diseases. Thus, phase separation and phase separating factors may serve as drug targets for disease treatment. Nevertheless, such associations have not yet been integrated into phase separation-related databases. Therefore, based on MloDisDB, a database for membraneless organelle factor–disease associations previously developed by our lab, we constructed PhaSeDis, the phase separation–disease association database. We increased the number of phase separation entries from 52 to 185, and supplemented the evidence provided by the original articles verifying the phase separation nature of the factors. Moreover, we included the information of interacting small molecules with low-throughput or high-throughput evidence that might serve as potential drugs for phase separation entries. PhaSeDis strives to offer comprehensive descriptions of each entry, elucidating how phase separating factors induce pathological conditions via phase separation and the mechanisms by which small molecules intervene. We believe that PhaSeDis would be very important in the application of phase separation regulation in treating related diseases. PhaSeDis is available at http://mlodis.phasep.pro.


  • Open Access

    PhaSeDis: A Manually Curated Database of Phase Separation–Disease Associations and Corresponding Small Molecules

    by Taoyu Chen, Guoguo Tang, Tianhao Li, Zhining Yanghong, Chao Hou, Zezhou Du, Liwei Ma, Tingting Li

    Biomacromolecules form membraneless organelles through liquid–liquid phase separation in order to regulate the efficiency of particular biochemical reactions. Dysregulation of phase separation might result in pathological condensation or sequestration of biomolecules, leading to diseases. Thus, phase separation and phase separating factors may serve as drug targets for disease treatment. Nevertheless, such associations have not yet been integrated into phase separation related databases. Therefore, based on MloDisDB, a database for membraneless organelle factor–disease association previously developed by our lab, we constructed PhaSeDis, the phase separation–disease association database. We increased the number of phase separation entries from 52 to 185, and supplemented the evidence provided by the original article verifying the phase separation nature of the factors. Moreover, we included the information of interacting small molecules with low or high-throughput evidence that might serve as potential drugs for phase separation entries. PhaSeDis strives to offer comprehensive descriptions of each entry, elucidating how phase separating factors induce pathological conditions via phase separation and the mechanisms by which small molecules intervene. We believe that PhaSeDis would be very important in the application of phase separation regulation in treating related diseases. PhaSeDis is available at http://mlodis.phasep.pro .